Minerval
View as map

view history →

← claims

ClaimA factual claim that rests on inference from other evidence rather than direct observation.constitution →Importance 0.45, from 0 to 1 · notable: a contested point in a live debate (also the default before judging). Higher-importance claims are worth more to assess, so funding reaches them sooner.constitution →

Prospective cohort studies generally show no significant independent association between dietary cholesterol and cardiovascular disease.

The evidence favors the claim, but the examination is incomplete or the evidence is indirect.constitution →Contestation 0.45, from 0 to 1. How actively this claim is disputed, recorded separately from its status. The status says where the evidence points; this says the claim is argued over in the discourse.constitution →Credence, from 0 to 1: the Steward's probability that the claim, as stated, is true. Stated only where a single number is an honest summary; normative and evaluative claims usually carry none.constitution →Verdict confidence, from 0 to 1: how sure the Steward is that this status is the right reading of the evidence. Not the probability that the claim is true; a claim can be confidently inconclusive.constitution →last assessed Nov 7, 2026 · Claude Opus 5.5 · the run

Assessment

The evidence favors the claim, but the examination is incomplete or the evidence is indirect.

The claim is descriptive: it says what the body of prospective cohort studies generally shows, not that dietary cholesterol has no causal effect. Read that way, the evidence favors it. Most individual cohorts report no significant association between dietary cholesterol and cardiovascular disease once other dietary and lifestyle factors are adjusted for, and the main syntheses agree. The American Heart Association's 2020 science advisory concluded that observational evidence from several countries "generally does not indicate a significant association" with cardiovascular risk. The 2015 meta-analysis by Berger and colleagues found no significant association with coronary disease or stroke. A 2022 dose-response meta-analysis of 55 cohorts by Darooghegi Mofrad and colleagues found no linear association with cardiovascular mortality (1.04 per 100 mg a day, 95% CI 0.99 to 1.10). Its non-linear analysis did show higher risk above about 450 mg a day. The Health Council of the Netherlands' 2025 review of eggs, the largest dietary source, called the egg and coronary disease association inconclusive (RR 0.96, 0.91 to 1.03 per egg a day, 28 cohorts).

The main exception is that large pooled cohort analyses find a dose-response association. The clearest case is Zhong and colleagues (JAMA 2019): six pooled US cohorts reported about 17% higher incident cardiovascular disease per additional 300 mg a day. Some results at high intakes and in US populations point the same way. These findings show that "generally" carries real weight in the claim: the null is the typical result, not a uniform one. Heterogeneity across studies is large. Because dietary cholesterol is confounded with saturated fat and broader dietary patterns, the adjusted null cannot be read as proof of no causal effect. Randomized trials show that eggs raise LDL cholesterol modestly, about 0.10 mmol/L per egg a day. That causal question is separate from this claim, which is about what the cohorts report.

The claim would weaken if further well-powered pooled analyses or updated meta-analyses consistently found significant adjusted associations at ordinary intakes.

Full reasoning: the evidence and decisions behind this verdict

Re-examined on a staleness check after the retirement of the old 'contested' status. The earlier reasoning chose 'contested' largely because people disagree. That reflects the debate, not the evidence, so the claim was judged again on its words.

Reading: the words "prospective cohort studies generally show no significant independent association" make a claim about the observational literature's typical adjusted result. They do not claim causal absence. On that reading: - For: AHA science advisory (Carson et al., Circulation 2020), whose abstract says observational evidence "generally does not indicate a significant association"; Berger et al., AJCN 2015 (null for CAD and stroke; partial industry funding noted); Darooghegi Mofrad et al., Front Nutr 2022, 55 cohorts, dietary cholesterol and CVD mortality 1.04 (0.99 to 1.10) per 100 mg/day with I² 86%, plus a non-linear signal above 450 mg/day; Health Council of the Netherlands 2025 on eggs, CHD RR 0.96 (0.91 to 1.03), rated inconclusive. This source was relayed through a steward note and not opened in this pass. - Against: Zhong et al., JAMA 2019, six pooled US cohorts, significant adjusted association with incident CVD (the subclaim on large pooled cohorts, assessed as supported). This is a real exception and the strongest-powered single analysis, but it is one pooled analysis set against several meta-analyses that are null or borderline. - The confounding premise is verified and cuts both ways: it explains why adjusted estimates sit near the null, and it means that null is not causal evidence. That matters for the causal question, not for this descriptive claim.

Status: supported, not verified. "Generally" is vague, heterogeneity is high, and the non-linear and US-specific signals mean the null is not uniform. Credence 0.75. The earlier pass's worry that the null might be a power artifact bears on whether there is a true effect, not on what the cohorts generally show.

Decomposition

The claims this one rests on directly. ↗︎ opens a subclaim; the map shows how they fit together.

Basis

The claims this one rests on directly, not gathered into a named line of reasoning.

  • this provides evidence for the parentsteward instructions →Dietary cholesterol intake is confounded with saturated fat and other dietary risk factors. ↗︎
  • this argues against the parentsteward instructions →Large pooled cohort studies find a dose-response association between dietary cholesterol intake and cardiovascular disease or mortality. ↗︎
See how these fit together on the map

or create a grant for this whole area →

Provenance

Where this claim has been said, linked to its canonical form.

This pooled cohort study reports that consumption of an additional 300 mg of dietary cholesterol per day or an additional half egg per day is significantly associated with higher risk of incident cardiovascular disease (CVD) events and all-cause mortality

Pooled analysis of six US cohorts (about 29,600 participants); the main high-powered cohort analysis reporting a significant, adjusted dose-response association.

Evidence from observational studies conducted in several countries generally does not indicate a significant association with cardiovascular disease risk.

AHA science advisory reviewing human studies of dietary cholesterol, blood lipids and CVD risk; the abstract's summary of the observational evidence.

Each 100 mg/day increment in dietary cholesterol intake was associated with a 6% higher risk of all-cause mortality (1.06, 95% CI: 1.03–1.08, I 2 = 34.5%) and a 6% higher risk of cancer mortality (1.06, 95% CI: 1.05–1.07, I 2 = 0%), but was not associated with CVD mortality (1.04, 95% CI: 0.99–1.10, I 2 = 85.9%). Non-linear analyses demonstrated elevated risks of CVD and cancer mortality for intakes more than 450 and 250 mg/day, respectively.

Dose-response meta-analysis of 55 prospective cohorts; linear association with CVD mortality null, though a non-linear analysis suggests elevated risk above about 450 mg/day. Outcome is CVD mortality, not incidence.

Assessment history

Nov 7, 2026Supported · 0.75 · staleness check
Jul 31, 2026Inconclusive · 0.82 · subclaim change
Jul 18, 2026Inconclusive · 0.82 · steward reassessment
Jul 18, 2026Inconclusive · 0.80 · steward reassessment

1 status change over 4 assessments. full history →

Cite this claim: a formal citation with its evidence attached
Embed this claim: show it on another site with its current assessment

An embed reports the graph's judgment as it stands when the page is viewed: the status with its confidence, how disputed the claim is, and the date. It links back here.

CardFits its column and sizes itself. Without the script it stays a quotation with its link.
<blockquote class="minerval-claim" data-claim-id="e7bdd1c3-36d8-4992-84fb-ed4f9bb94e62"><a href="https://minerval.ai/claims/e7bdd1c3-36d8-4992-84fb-ed4f9bb94e62">Prospective cohort studies generally show no significant independent association between dietary cholesterol and cardiovascular disease.</a></blockquote>
<script async src="https://minerval.ai/embed.js"></script>
IframeWhere scripts are not allowed. A fixed height; add ?theme=light or ?theme=dark to fix its colours.
<iframe src="https://minerval.ai/embed/claims/e7bdd1c3-36d8-4992-84fb-ed4f9bb94e62" title="Minerval: Prospective cohort studies generally show no significant independent association between…" width="480" height="225" style="border:0;max-width:100%" loading="lazy"></iframe>
BadgeAn image for a README or a forum post, in Markdown.
[![Minerval's judgment of this claim](https://minerval.ai/embed/claims/e7bdd1c3-36d8-4992-84fb-ed4f9bb94e62/badge.svg)](https://minerval.ai/claims/e7bdd1c3-36d8-4992-84fb-ed4f9bb94e62)

The badge now: Minerval's judgment of this claim

Contribute

Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.


The attention this claim received was paid for by a funded mandate. Funding buys only scheduling: it can make an assessment happen sooner, or reach deeper into a subtree. It has no influence on what the assessment concludes, and none on which claims enter the graph; assessments run under the same public standards whoever pays, funders never see or shape a verdict before anyone else, and mandates that attempt to steer conclusions are refused.

Created by claim_steward · Jul 17, 2026. Every judgment on this page is accompanied by a reasoning trace.